Neuroimmunophilin ligands improve functional recovery and increase axonal growth after spinal cord hemisection in rats

Journal of Neurotrauma

Volumn 22, Issue 10, 2005, Pages 1150-1161

  Voda, Jan ^a   Yamaji, Takayuki ^c   Gold, Bruce G ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c ASTELLAS PHARMA INC   (Japan)

Author keywords

FK1706; FK506; Hemisection; Immunophilin; Neuroimmunophilin ligands; Nonimmunosuppressant derivative; Spinal Cord

Indexed keywords

AMOXICILLIN; BACITRACIN ZINC; BUPRENORPHINE; CYCLOSPORIN A; DIMETHYL SULFOXIDE; FK 1706; GOLD; IMMUNOLOGIC AGENT; NEUROIMMUNOPHILIN; POLYMYXIN B; TACROLIMUS; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DRUG MECHANISM; FLUORESCENCE MICROSCOPY; MALE; MOTOR PERFORMANCE; NERVE FIBER GROWTH; NERVE REGENERATION; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; RAT; RED NUCLEUS; SPINAL CORD HEMISECTION; SPINAL CORD INJURY; WALKING;

ANIMALS; AXONS; AXOTOMY; FUNCTIONAL LATERALITY; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY, FLUORESCENCE; NERVE REGENERATION; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; RED NUCLEUS; SPINAL CORD; SPINAL CORD INJURIES; TACROLIMUS;

EID: 27444436746     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.2005.22.1150     Document Type: Article

References (60)

1. BAVETTA, S., HAMLYN, P.J., BURNSTOCK, G., LIEBERMAN, A.R., and ANDERSON, P.N. (1999). The effects of FK506 on dorsal column axons following spinal cord injury in adult rats: neuroprotection and local regeneration. Exp. Neurol. 158, 382-393.
2. BONNI, A., BRUNET, A., WEST, A.E., DATTA, S.R., TAKASU, M.A., and GREENBERG, M.E. (1999). Cell survival promoted by the ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science 286, 1358-1362.
3. BROWN, L.T., JR. (1971). Projections and termination of the corticospinal tract in rodents. Exp. Brain Res. 13, 432-450.
4. CARVER, L.A., LAPRES, J.J., JAIN, S., DUNHAM, E.E., and BRADFIELD, C.A. (1998). Characterization of the Ah receptor-associated protein, ARA9. J. Biol. Chem. 273, 33580-33587.
5. DIAZ-RUIZ, A., RIOS, C., DUARTE, I., et al. (1999). Cyclosporin-A inhibits lipid peroxidation after spinal cord injury in rats. Neurosci. Lett. 266, 61-64.
6. FOUAD, K., SCHNELL, L., BUNGE, M.B., SCHWAB, M.E., LIEBSCHER, T., and PEARSE, D.D. (2005). Combining Schwann cell bridges and olfactory-ensheathing glia grafts with chondroitinase promotes locomotor recovery after complete transection of the spinal cord. J. Neurosci. 25, 1169-1178.
7. FREMAN, D.A., KLEE, C.B., BIERER, B.E., and BURAKOFF, S.J. (1992). Calcineurin phosphatase activity in T lymphocytes is inhibited by FK506 and cyclosporin A. Proc. Natl. Acad. Sci. USA. 89, 3686-3690.
8. GIORDANI, F., BENETOLLI, A., FAVERO-FILHO, L.A., LIMA, K.C., CESTARI JUNIOR, L., and MILANI, H. (2003). Tacrolimus (FK506) reduces ischemia-induced hippocampal damage in rats: a 7- and 30-day study. Braz. J. Med. Biol. Res. 36, 495-502.
9. GOLD, B.G. (1999). FK506 and the role of the immunophilin FKBP-52 in nerve regeneration. Drug Metab. Rev. 31, 649-663.
10. GOLD, B.G. (2000). Neuroimmunophilin ligands and the role of steroid hormone chaperone proteins in nerve regeneration, in: Immunophilins in the Brain. FKBP-Ligands: Novel Strategies for the Treatment of Neurodegenerative Disorders. B.G. Gold, G. Fischer, and T. Herdegen (eds), Prous Science: Barcelona, pps. 3-22.
11. GOLD, B.G., and VILLAFRANCA, J.E. (2003). Neuroimmunophilin ligands: the development of novel neuroregenerative/neuroprotective compounds. Curr. Top. Med. Chem. 3, 1368-1375.
12. GOLD, B.G., and ZHONG, Y.P. (2004). FK506 requires stimulation of the extracellular signal regulated kinase 1/2 and the steroid receptor chaperone protein p23 for neurite elongation. Neurosignals 13, 122-129.
13. GOLD, B.G., STORM-DICKERSON, T., and AUSTIN, D.R. (1994). The immunosuppressant FK506 increases functional recovery and nerve regeneration following peripheral nerve injury. Restor. Neurol. Neurosci. 6, 287-296.
14. GOLD, B.G., KATOH, K., and STORM-DICKERSON, T. (1995). The immunosuppressant FK506 increases the rate of axonal regeneration in rat sciatic nerve. J. Neurosci. 15, 7509-7516.
15. GOLD, B.G., ZELENY-POOLEY, M., WANG, M.-S., CHATURVEDI, P., and ARMISTEAD, D.M. (1997). A non-immunosuppressant FKBP-12 ligand increases nerve regeneration. Exp. Neurol. 147, 269-278.
16. GOLD, B.G., GORDON, H.S., ZELENY-POOLEY, M., and WANG, M.S. (1998). FK506 produces regeneration, but not neuroprotection, of nigrostriatal dopaminergic neurons in MPTP-treated mice. Brain Pathol. 8, 583.
17. GOLD, B.G., DENSMORE, V., SHOU, W., MATZUK, M.M., and GORDON, H.S. (1999). Immunophilin FK506-binding protein 52 (not FK506-binding protein 12) mediates the neurotrophic action of FK506. J. Pharmacol. Exp. Ther. 289, 1202-1210.
18. GOLD, B.G., VODA, J., YU, X., and GORDON, G. (2004a). The immunosuppressant FK506 elicits a neuronal heat shock response and protects against acrylamide neuropathy. Exp. Neurol. 187, 160-170.
19. GOLD, B.G., VODA, J., YU, X., MCKEON, G., and BOURDETTE, D.N. (2004b). FK506 and a nonimmunosuppressant derivative reduce axonal and myelin damage in experimental autoimmune encephalomyelitis: neuroimmunophilin ligand-mediated neuroprotection in a model of multiple sclerosis. J. Neurosci. Res. 77, 367-377.
20. GOLD, B.G., UDINA, E., BOURDETTE, D., and NAVARRO, X. (2004c). Neuroregenerative and neuroprotective actions of neuroimmunophilin compounds in traumatic and inflammatory neurophathies. Neurol. Res. 26, 371-380.
21. HOWARD, C.V., and REED, M.G. (1998). Unbiased Stereology, Three-Dimensional Measurement in Microscopy, 1st ed. Bios Scientific Publishers, Springer: New York.
22. HUISMAN, A.M., KUYPERS, H.G., CONDE, F., and KEIZER, K. (1983). Collaterals of rubrospinal neurons to the cerebellum in rat. A retrograde fluorescent double labeling study. Brain Res. 264, 181-196.
23. HUISMAN, A.M., KUYPERS, H.G., and VERBURGH, C.A. (1981). Quantitative differences in collateralization of the descending spinal pathways from red nucleus and other brain stem cell groups in rat as demonstrated with the multiple fluorescent retrograde tracer technique. Brain Res. 209, 271-286.
24. JIN, K., MAO, X.O., ZHU, Y., and GREENBERG, D.A. (2002). MEK and ERK protect hypoxic cortical neurons via phosphorylation of Bad. J. Neurochem. 80, 119-125.
25. KAMADA, T., KODA, M., DEZAWA, M., et al. (2005). Transplantation of bone marrow stromal cell-derived Schwann cells promotes axonal regeneration and functional recovery after complete transection of adult rat spinal cord. J. Neuropathol. Exp. Neurol. 64, 37-45.
26. KAPLAN, D.R., and MILLER, F.D. (2000). Neurotrophin signal transduction in the nervous system. Curr. Opin. Neurobiol. 10, 381-391.
27. KINO, T., HATANAKA, H., HASHIMOTO, M., and NISHIYAMA, H. (1987). FK-506, a novel immunosuppressant isolated from a streptomyces. I. Fermentation, isolation, and physio-chemical and biological characteristics. J. Antibiot. 40, 1249-1255.
28. KLETTNER, A., and HERDEGEN, T. (2003). The immunophilin-ligands FK506 and V-10,367 mediate neuroprotection by the heat shock response. Br. J. Pharmacol. 138, 1004-1012.
29. LANG-LAZDUNSKI, L., HEURTEAUX, C., DUPONT, H., ROUELLE, D., WIDMANN, C., and MANTZ, J. (2001). The effects of FK506 on neurologic and histopathologic outcome after transient spinal cord ischemia induced by aortic cross-clamping in rats. Anesth. Analg. 92, 1237-1244.
30. LIU, J., FARMER, J.D., LANE, W.S., FRIEDMAN, J., WEISSMAN, L, and SCHREIBER, S.L. (1991). Calcineurin is a common target of cyclophilin- cyclosporin A and FKBP-FK506 complexes. Cell 66, 807-815.
31. LIU, Y., HIMES, B.T., MURRAY, M., TESSLER, A., and FISCHER, I. (2002). Grafts of BDNF-producing fibroblasts rescue axotomized rubrospinal neurons and prevent their atrophy. Exp. Neurol. 178, 150-164.
32. LUO, J., LI, N., PAUL ROBINSON, J., and SHI, R. (2002). Detection of reactive oxygen species by flow cytometry after spinal cord injury. J. Neurosci. Methods 120, 105-112.
33. LYONS, W.E., GEORGE, E.B., DAWSON, T.M., STEINER, J.P., and SNYDER, S.H. (1994). Immunosuppressant FK506 promotes neurite outgrowth in cultures of PC12 cells and sensory ganglia. Proc. Natl. Acad. Sci. USA 91, 3191-3195.
34. LYONS, W.E., STEINER, J.P., SNYDER, S.H., and DAWSON, T.M. (1995). Neuronal regeneration enhances the expression of the immunophilin FKBP-12. J. Neurosci. 15, 2985-2994.
35. MADSEN, J.R., MACDONALD, P., IRWIN, N., et al. (1998). Tacrolimus (FK506) increases neuronal expression of GAP-43 and improves functional recovery after spinal cord injury in rats. Exp. Neurol. 154, 673-683.
36. MURAKI, T., SASAKI, Y., GIDDING, J.C., ISHII, H., KANEKO, T., and YAMAMOTO, J. (1995). Antithrombotic effect of FK506 versus prothrombotic effect of cyclosporine in vivo. Transplantation. 60, 308-310.
37. MURAKI, T., TAKA, T., NOGUCHI, T., ISHII, H., SEKI, J., and YAMAMOTO, J. (1998). Effects of cyclosporine and FK506 on in vitro high shear-induced platelet reactivity in rat and human non-anticoagulated blood. Transplantation 65, 1132-1134.
38. MURRAY, H.M., and GURULE, M.E. (1979). Origin of the rubrospinal tract of the rat. Neurosci. Lett. 14, 19-23.
39. PALLADINI, G., CARONTI, B., POZZESSERE, G., et al. (1996). Treatment with cyclosporine A promotes axonal regeneration in rats submitted to transverse section of the spinal cord. II. Recovery of function. J. Brain Res. 37, 145-153.
40. PEARSON, K.G. (2000). Plasticity of neuronal networks in the spinal cord: modifications in response to altered sensory input. Prog. Brain Res. 128, 61-70.
41. r of 63,000, 56,000, and 50,000. J. Biol. Chem. 266, 6708-6713.
42. PRICE, R.D., YAMAJI, T., YAMAMOTO, H., et al. (2005). FK1706, a novel non-immunosuppressive immunophilin ligand: neurotrophic activity and mechanism of action. Eur. J. Pharmacol. (in press).
43. RABCHEVSKY, A.G., FUGACCIA, I., SULLIVAN, P.G., and SCHEFF, S.W. (2001). Cyclosporin A treatment following spinal cord injury to the rat: Behavioral effects and stereological assessment of tissue sparing. J. Neurotrauma 18, 513-522.
44. ROSSIGNOL, S., BOUYER, L., BARTHELEMY, D., LANGLET, C., and LEBLOND, H. (2002). Recovery of locomotion in the cat following spinal cord lesions. Brain Res. Brain Res. Rev. 40, 257-266.
45. SANCHEZ, E.R. (1990). Hsp56: a novel heat shock protein associated with untransformed steroid receptor complexes. J. Biol. Chem. 265, 22067-22070.
46. SCHREIBER, S.L., and CRABTREE, G.R. (1992). The mechanism of action of cyclosporin A and FK506. Immunol. Today 13, 136-142.
47. SHARKEY, J., and BUTCHER, S.P. (1994). Immunophilins mediate the neuroprotective effects of FK506 in focal cerebral ischaemia. Nature 371, 336-339.
48. SHIEH, J.Y., LEONG, S.K., and WONG, W.C. (1983). Origin of the rubrospinal tract in neonatal, developing, and mature rats. J. Comp. Neurol. 214, 79-86.
49. SIGAL, N.H., and DUMONT, F.J. (1992). Cyclosporin A, FK-506, and Rapamycin: pharmacologic probes of lymphocyte signal transduction. Annu. Rev. Immunol. 10, 519-560.
50. STEINER, J.P., CONNOLLY, M.A., VALENTINE, H.L., et al. (1997a). Neurotrophic actions of nonimmunosuppressive analogues of immunosuppressive drugs FK506, rapamycin and cyclosporin A. Nat. Med. 3, 421-428.
51. STEINER, J.P., HAMILTON, G.S., ROSS, D.T., et al. (1997b). Neurotrophic immunophilin ligands stimulate structural and functional recovery in neurodegenerative animal models. Proc. Natl. Acad. Sci. USA 94, 2019-2024.
52. SULAIMAN, O.A., VODA, J., GOLD, B.G., and GORDON, T. (2002). FK506 increases peripheral nerve regeneration after chronic axotomy but not after chronic Schwann cell denervation. Exp. Neurol. 175, 127-137.
53. TAI, P.-K.K., ALBERS, M.W., CHANG, H., FABER, L.E., and SCHREIBER, S.L. (1992). Association of a 59-kilodalton immunophilin with the glucocorticoid receptor complex. Science 256, 1315-1318.
54. TERADA, N., OR, R., WEINBERG, K., DOMENICO, J., LUCAS, J.J., and GELFAND, E.W. (1992). Transcription of IL-4 genes is not inhibited by cyclosporin A in competent T cells. J. Biol. Chem. 267, 21207-21210.
55. TOCCI, M.J., MATKOVICH, D.A., MATKOVICH, K., et al. (1989). The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes. J. Immunol. 143, 718-726.
56. UDINA, E., VODA, J., GOLD, B.G., and NAVARRO, X. (2003). Comparative dose-dependence study of FK506 on transected mouse sciatic nerve repaired by allograft or xenograft. J. Peripher. Nerv. Syst. 8, 145-154.
57. WALDRON, H.A., and GWYN, D.G. (1969). Descending nerve tracts in the spinal cord of the rat. I. Fibers from the midbrain. J. Comp. Neurol. 137, 143-153.
58. WANG, M.S., ZELENY-POOLEY, M., and GOLD, B.G. (1997). Comparative dose-dependence study of FK506 and cyclosporin A on the rate of axonal regeneration in rat sciatic nerve. J. Pharmacol. Exp. Ther. 282, 1084-1093.
59. WANG, W., POST, J.I., DOW, K.E., SHIN, S.H., RIOPELLE, R.J., and ROSS, G.M. (1999). Zinc and copper inhibit nerve growth factor-mediated protection from oxidative stress-induced apoptosis. Neurosci. Lett. 259, 115-118.
60. ZAWADZKA, M., and KAMINSKA, B. (2003). Immunosuppressant FK506 affects multiple signaling pathways and modulates gene expression in astrocytes. Mol. Cell Neurosci. 22, 202-209.